Literature DB >> 17445114

Topiramate for migraine prophylaxis among Chinese population.

Ho Lun Li1, Patrick Kwan, Howan Leung, Evelyn Yu, Tak Hong Tsoi, Andrew Che Fai Hui, Bun Sheng, Kwok Kwong Lau.   

Abstract

We evaluated the efficacy and safety of topiramate for migraine prophylaxis among Chinese patients in a multicenter prospective observational study. We found that topiramate at low doses was effective in preventing migraine headache in Chinese patients and was generally well tolerated. There was no difference in baseline headache frequency or intensity between responders and nonresponders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445114     DOI: 10.1111/j.1526-4610.2007.00763_3.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  4 in total

1.  The pharmacological management of migraine, part 2: preventative therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-08

2.  Topiramate: safety and efficacy of its use in the prevention and treatment of migraine.

Authors:  Ginger C Minton; April D Miller; P Brandon Bookstaver; Bryan L Love
Journal:  J Cent Nerv Syst Dis       Date:  2011-06-23

3.  Efficacy of zonisamide in migraineurs with nonresponse to topiramate.

Authors:  Jin-Young Chung; Min-Wook Kim; Manho Kim
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

Review 4.  Advances in topiramate as prophylactic treatment for migraine.

Authors:  Chuan Hu; Yixin Zhang; Ge Tan
Journal:  Brain Behav       Date:  2021-09-02       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.